Posts for Category: Research

The Centers for Medicare & Medicaid Services strengthened its commitment to monitoring patient safety with the addition of several PQA safety measures to the 2027 Part D Star Ratings (Polypharmacy: Use of Multiple Anticholinergic Medications in Older Adults [POLY-ACH], and Concurrent Use of Opioids and Benzodiazepines [COB]) and Display Page (Polypharmacy: Use of Multiple CNS-Active Medications in Older Adults [POLY-CNS]).

A research partnership between PQA, Merck, and the University of Mississippi focused on three PQA adherence measures to continue to monitor their impact.   Using administrative claims data from Optum’s de-identified Clinformatics® Data Mart Database, the project examined Medicare Advantage enrollees who were taking either diabetes, renin-angiotensin system antagonist (RASA), or statin medications.  Findings suggest the average patient-level adherence rate was between 84%-89% across the three medication classes using a modified […]